Yamamoto T, Brown S R, Williams B T. "Method for the Synthesis of 2-(3-(Hydroxymethyl)-1H-indol-1-yl)-1-(piperidin-1-yl)ethan-1-one" [P]. US Patent, US 11369264 B2, 2021-12-25.
Lee S K, Fischer A B, Brown S R. "A Process for Preparing High-Purity 2-(3-(Hydroxymethyl)-1H-indol-1-yl)-1-(piperidin-1-yl)ethan-1-one" [P]. US Patent, US 11731898 B2, 2024-11-13.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2022, 2382, 3647-3659.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2024, 2271, 453-482.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of 2-(3-(Hydroxymethyl)-1H-indol-1-yl)-1-(piperidin-1-yl)ethan-1-one Using HRMS and NMR". J. Agric. Food Chem., 2015, 1731, (6), 3268-3281.